ACOG · Alpha Cognition Inc.

Track ACOG — free

$9.15 +0.05 (+0.55%) At close · Oct 5

Rebalance outlook locked

Market Cap

$186.20M

21.78M

Volume · Oct 5 52.6K Avg daily vol (3M) 123.89K

Up next

Latest filing: 10-Q

filed Aug 13, 2026

Q1 2026 earnings call transcript

call held Mar 31, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$15.26M

Trailing 12 months

Net income (TTM)

−$21.01M

Trailing 12 months

Revenue growth YoY

+267.6%

Year over year

Operating margin

-174.7%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

-16.7%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$41.38M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+35.9%

Year over year · more shares

Price change (1Y)

+22.3%

Trailing year

Short interest

1.0%

Latest settlement · 2.2 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Strong Buy Momentum Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 15.5 · calm Equity put/call 0.59

Technical

price trend

Strong Buy

50 / 200-day cross No cross

Price vs 200-day avg +33%

above

Price vs 50-day avg +2%

above

RSI (14) 55

neutral

MACD trend Positive

52-week position 89%

near high

Momentum

relative strength

Strong

1-month return −4%

trailing

6-month return +41%

trailing

YTD return +41%

this year

Relative strength +29%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $9 › 200d $7 — 50d above 200d

Institutional flow Accumulating

+4% holders QoQ · +1 funds added

Insider flow Accumulating

Net +$3.6M over 90 days · 0% sells

Short interest Falling

0.96% of float · ▼ -1.0% MoM · 2.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

26 holders — mid 1-yr range

Squeeze score 52

elevated · 0–100

Fundamentals

Fair

EPS growth +42%

Y/Y

Free cash flow $-20.7M

Quant / Vol

risk profile

Very High

Volatility 64%

annualized · 1-yr

Max drawdown −42%

past year

ATR 6.1%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Mar 31, 2026

Operating expense · full year 2026 Initiated $54M – $58M

Full year 2026 expense guidance · full year 2026 Initiated $54M – $58M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy

0 · 2 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+33% Bullish

Price vs 50-day avg

+2% Bullish

RSI (14)

55 Neutral

MACD trend

Positive Bullish

52-week position

89% Bullish

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $9 › 200d $7 — 50d above 200d

Institutional flow Accumulating

+4% holders QoQ · +1 funds added

Insider flow Accumulating

Net +$3.6M over 90 days · 0% sells

Short interest Falling

0.96% of float · ▼ -1.0% MoM · 2.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

26 holders — mid 1-yr range

Price context

position in its 52-week range

Range low $5 Now $9 · 89% Range high $10

vs 200-day avg +33% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ACOG Alpha Cognition Inc. this stock	$186.20M	+40.8%	—	—	1.0%
VRTX Vertex Pharmaceuticals Inc / Ma	$133.37B	+11.1%	+46.2%	30.7	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$81.13B	-5.9%	+20.8%	19.5	2.5%
MRNA Moderna, Inc.	$79.40B	+589.1%	+4.3%	—	8.2%
CSLLY Csl Ltd	$61.25B	—	—	—	0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

% held: 48.2%
Net QoQ: -43.5K sh
Top holder: Opaleye Management Inc.

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

209.2K

Days to cover: 2.2d
Change: -2.1K sh

View

Short Volume

Short vol %

41%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

3.7K

Value: $35.1K
As of: Sep 8, 2026

View

Off-Exchange

Off-exchange %

35.5%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net buying

Net (90d)

+$3.6M

Buyers / Sellers: 2 / 0

Buyers Sellers

View

Financials

Revenue (FY)

$10.2M

Net income (FY): $-20.7M
EPS diluted: $-1.18

View

Filings

SEC Filings

Latest

10-Q

Filed: Aug 13, 2026
This year: 12

View

Exempt Offerings

Offering

$346.9K

Filed: Nov 18, 2024

View

Earnings & Events

Webcasts

Last webcast

Mar 31, 2026

View

Performance

	5D	20D	120D	MTD	YTD
ACOG	+6.4%	-3.9%	+41.0%	+1.7%	+40.8%
SPY	+1.2%	+0.6%	+11.6%	+1.6%	+13.6%
vs SPY	+5.2%	-4.5%	+29.4%	+0.1%	+27.2%

Key facts CIK 1655923 CUSIP 02074J501 Visit website Investor relations

ACOG · Alpha Cognition Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance